CRISPR

CRISPR2-il10ra

ID
ZDB-CRISPR-230622-4
Name
CRISPR2-il10ra
Previous Names
None
Target
Sequence
5' - GGTACGGGGGCTTCATTGGG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 15
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
psi71 il10ra
Expression
Gene expression in Wild Types + CRISPR2-il10ra
No data available
Phenotype
Phenotype resulting from CRISPR2-il10ra
No data available
Phenotype of all Fish created by or utilizing CRISPR2-il10ra
Phenotype Fish Conditions Figures
neuromast macrophage il4r.1 expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal il10rapsi71/+; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage il4r.1 expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage manf expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage interleukin-4-mediated signaling pathway increased efficacy, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
macrophage polyamine biosynthetic process increased efficacy, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast macrophage odc1 expression increased amount, abnormal il10rapsi71/psi71; gl22Tg chemical treatment by environment: neomycin Fig. 4 with image from Denans et al., 2022
neuromast hair cell synapse assembly decreased process quality, abnormal il10rapsi71/psi71; stat6xt53/xt53 chemical treatment by environment: neomycin Fig. 5 with image from Denans et al., 2022
neuromast macrophage Ab2-vamp2 labeling decreased amount, abnormal il10rapsi71/psi71; stat6xt53/xt53 chemical treatment by environment: neomycin Fig. 5 with image from Denans et al., 2022
Citations
TSV
1 - 1 of 1
Show
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.